Press Review (January 5, 2013) – Revue de presse (5 janvier 2013)

Bayer's Nexavar meets goal in thyroid cancer trial

German drugmaker Bayer said its cancer treatment Nexavar reached a goal of improving the survival of patients with a certain type of thyroid cancer in a late-stage clinical trial.

By Maria Sheahan and Frank Siebelt. In Reuters

http://www.reuters.com/article/2013/01/03/us-bayer-nexavar-idUSBRE90204X20130103

Updated Tool Now Available to Predict Prostate Cancer Spread

Prostate cancer experts at Johns Hopkins have developed an updated version of the Partin Tables, a tool to help men diagnosed with prostate cancer and their doctors to better assess their chance of a surgical cure.

In Science Daily (press release)

http://www.sciencedaily.com/releases/2013/01/130103073050.htm

Novel Approach To Identifying Cancer Targets

A new online way of quickly prioritizing the best druggable cancer targets has successfully identified 46 previously overlooked targets. The research, funded by Cancer Research UK, was published in the journal Nature Reviews Drug Discovery.

By Joseph Nordqvist. In Medical News Today

http://www.medicalnewstoday.com/articles/254541.php

Common Data Determinants of Recurrent Cancer Are Broken, Mislead Researchers

In order to study the effectiveness or cost effectiveness of treatments for recurrent cancer, you first have to discover the patients in medical databases who have recurrent cancer. Generally studies do this with billing or treatment codes -- certain codes should identify who does and does not have recurrent cancer. A recent study published in the journal Medical Care shows that the commonly used data determinants of recurrent cancer may be misidentifying patients and potentially leading researchers astray.

In Science Daily (press release)

http://www.sciencedaily.com/releases/2013/01/130102140533.htm

Cancer Biomarker Studies Retracted

Researchers from Johns Hopkins University School of Medicine have retracted two papers involving colon cancer biomarkers.

By Bob Grant. In The Scientist

http://www.the-scientist.com/?articles.view/articleNo/33831/title/Cancer-Biomarker-Studies-Retracted/

New Standards of Practice Needed in Cancer Tissue Sampling

Genomics is poised to become a major force in cancer care, and therapy guided by genetics is being embraced within established strategies for the treatment of a number of malignancies.

By Roxanne Nelson. In Medscape

http://www.medscape.com/viewarticle/776975

New Genetic Links to Colorectal Cancer Identified

Three new genetic links to colorectal cancer have been identified using a large genome-wide study of more than 28,000 individuals.

By Anna Azvolinsky. ,In Cancer Network

http://www.cancernetwork.com/colorectal-cancer/content/article/10165/2121284

Knowing You Carry a Cancer Gene

I jogged into the Stanford Cancer Clinic with my boyfriend, the youngest people there by two decades. We stood there sweating and holding hands, a jarring sight in the sickly light.

“You are 18, right?” the receptionist asked. Behind me, a woman so gaunt that her cheekbones protruded rolled by in a wheelchair. The oncologist called me alone to the exam room, and I told her the story I had revealed to more doctors than friends: I carry the BRCA1 mutation, which gives you a 98 percent chance of developing cancer.

By Emma Pierson. In New York Times (blog)

http://well.blogs.nytimes.com/2012/12/31/carrying-a-cancer-gene-unsure-i-want-to-know/

Milk-Producing Protein Linked To Aggressive Breast Cancer: Study

The discovery that a protein which triggers milk production in women may also be responsible for making breast cancers aggressive could open up new opportunities for treatment of the most common and deadliest form of cancer among women.

In Huffington Post

http://www.huffingtonpost.com/2012/12/28/milk-producing-protein-aggressive-breast-cancer_n_2373422.html

Il est temps de redéfinir ce qu'est vraiment un cancer

Il n'est pas du ressort de la science de définir la santé, car sa subjectivité la rend incompatible avec les impératifs de démonstration et de preuve.

Dans Le Monde

http://www.lemonde.fr/sciences/article/2013/01/03/il-est-temps-de-redefinir-ce-qu-est-vraiment-un-cancer_1812637_1650684.html

Bayer: résultat positif dans le cancer de la thyroïde.

Bayer HealthCare et l'américain Onyx ont annoncé jeudi le résultat positif d'une étude de phase III sur un traitement du cancer de la thyroïde.

Dans Le Figaro

http://bourse.lefigaro.fr/indices-actions/actu-conseils/bayer-resultat-positif-dans-le-cancer-de-la-thyroide-335994

Troisième plan Cancer : la prévention est la première priorité

Profitant de la 4e édition des Rencontres annuelles à l'institut national du Cancer (INCa) le 4 décembre dernier, François Hollande a annoncé le lancement d'un troisième plan Cancer - le premier lancé en 2003 par le président Jacques Chirac a permis la création de l'INCa, le deuxième a été initié en 2008 par le président Nicolas Sarkozy.

Par Jacques Cofard. Sur Medscape France  

http://www.medscape.fr/oncologie/articles/1492225/

Le cancer au cinéma. Poignant et peu réaliste [Vidéos]‎

Une majorité de malades jeunes et de femmes, des pathologies « choisies », une intensité dramatique à l’annonce du diagnostic, peu de scènes évoquant le traitement et la rémission… C’est la version grand écran du cancer.

Dans Ouest-France

http://www.ouest-france.fr/actu/actuDet_-Le-cancer-au-cinema.-Poignant-et-peu-realiste-[Videos]_46583-2149179_actu.Htm

Le cancer, principale cause des inégalités sociales en matière de santé

Les cadres sont en meilleure santé que les ouvriers ou les employés, et ils vivent nettement plus longtemps. Ce constat des inégalités sociales en matière de santé, qui n'est pas nouveau, est conforté par les dernières statistiques passées au crible par le Haut Conseil pour l'avenir de l'assurance-maladie, dans un rapport publié il y a quelques jours.

Par Vincent Collen. Dans Les Echos

http://www.lesechos.fr/entreprises-secteurs/grande-consommation/actu/0202470691953-le-cancer-principale-cause-des-inegalites-sociales-en-matiere-de-sante-524223.php